Laurel Wealth Advisors, Inc. Pfizer Inc Transaction History

Laurel Wealth Advisors, Inc.

$1.01 Billion
Q4 2022

A detailed history of Laurel Wealth Advisors, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Laurel Wealth Advisors, Inc. holds 82,624 shares of PFE stock, worth $2.18 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

82,624

Previous 79,558 3.85%

Holding current value

$2.18 Million

Previous $3.48 Million 21.49%

% of portfolio

0.42%

Previous 0.37%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $128,005 - $167,097	3,066 Added 3.85%	82,624 $4.23 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $619,247 - $755,946	-14,151 Reduced 15.1%	79,558 $3.48 Million
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $121,257 - $143,773	-2,606 Reduced 2.71%	93,709 $4.91 Million
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $1.58 Million - $1.96 Million	-34,644 Reduced 26.45%	96,315 $4.99 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $1.4 Million - $2.08 Million	33,960 Added 35.01%	130,959 $7.73 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $342,142 - $439,511	-8,717 Reduced 8.25%	96,999 $4.17 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $456,739 - $517,408	12,719 Added 13.68%	105,716 $4.14 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $159,311 - $179,671	-4,757 Reduced 4.87%	92,997 $3.37 Million
Q4 2020 Mar 03, 2021	BUY	$33.47 - $42.56 $864,094 - $1.1 Million	25,817 Added 35.89%	97,754 $3.6 Million
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $71,882 - $84,334	2,264 Added 3.25%	71,937 $2.64 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $192,768 - $233,856	6,400 Added 10.11%	69,673 $2.28 Million
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $133,311 - $190,473	-4,932 Reduced 7.23%	63,273 $2.07 Million
Q4 2019 Feb 13, 2020	SELL	$32.92 - $37.36 $486,755 - $552,404	-14,786 Reduced 17.82%	68,205 $2.67 Million
Q3 2019 Nov 13, 2019	BUY	$32.49 - $42.13 $544,727 - $706,351	16,766 Added 25.32%	82,991 $2.98 Million
Q2 2019 Aug 13, 2019	SELL	$36.98 - $41.52 $15,494 - $17,396	-419 Reduced 0.63%	66,225 $2.87 Million
Q1 2019 May 16, 2019	BUY	$37.5 - $41.2 $2.21 Million - $2.43 Million	59,063 Added 779.09%	66,644 $2.83 Million
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $2.35 Million - $2.68 Million	-61,154 Reduced 88.97%	7,581 $313,000
Q3 2018 Nov 15, 2018	BUY	$34.47 - $41.81 $95,516 - $115,855	2,771 Added 4.2%	68,735 $3.03 Million
Q2 2018 Aug 20, 2018	BUY	$32.98 - $35.16 $188,579 - $201,044	5,718 Added 9.49%	65,964 $2.39 Million
Q1 2018 May 16, 2018	SELL	$31.91 - $37.02 $139,159 - $161,444	-4,361 Reduced 6.75%	60,246 $2.14 Million
Q4 2017 Feb 15, 2018	BUY	$33.26 - $35.29 $261,722 - $277,697	7,869 Added 13.87%	64,607 $2.34 Million
Q3 2017 Nov 14, 2017	SELL	$31.0 - $34.15 $38,316 - $42,209	-1,236 Reduced 2.13%	56,738 $2.03 Million
Q2 2017 Aug 15, 2017	BUY	N/A	57,974	57,974 $1.95 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurel Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Laurel Wealth Advisors, Inc. with notifications on news.

Account

Laurel Wealth Advisors, Inc. Pfizer Inc Transaction History